Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

DCPA is a chronic skin condition affecting the lower limbs, mainly in men, with unclear causes and treatments that often don't work well.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

DPCP works best for alopecia areata, but more research is needed for better treatments.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

A man developed severe skin reactions after using a treatment for hair loss.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

DPCP is more effective than tretinoin gel for treating severe alopecia.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.